Answers are grounded in this paper and cite their sources.
In pharmacotherapy and drug discovery, understanding potential interactions between drugs is crucial for providing patient safety and optimizing treatment outcomes. While much research has focused on identifying drug-drug interactions (DDIs), there is a growing need to uncover non-interacting drug pairs. Non-interactions can be as significant as interactions, offering valuable insights into safe co-prescription practices. In this study, we introduce a groundbreaking approach to DDI detection by employing community detection methods: a clustering approach applied to a modified adjacency matrix. We then used the silhouette criteria to determine the optimal number of clusters, ensuring that non-interacting drugs are accurately represented in distinct groups. This method leverages the inherent structure of the modified adjacency matrix to differentiate between interacting and non-interacting drug pairs accurately. We demonstrated the effectiveness of our method through extensive experiments on real-world datasets, achieving an accuracy rate of 95.3% in predicting non-interactions. Our results highlight our proposed technique's reliability and efficiency in identifying safe drug combinations while minimizing the adverse effects of unintended interactions.
No takes yet. Share an insight, caveat, or question.
Shamami et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: